# Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection

> **NCT04728919** · — · UNKNOWN · sponsor: **Tampere University Hospital** · enrollment: 82 (actual)

## Conditions studied

- COVID-19
- SARS-CoV-2 Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04728919
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2023-01-15
- **Final completion:** 2024-01-15
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04728919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04728919, "Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04728919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*